Find a Research Expert

Experts
 Menu

Kathy Gately

Institution

Trinity College Dublin

Contact

Subjects

Medicine & Nursing

Biochemistry

Details
Publications 22
As first author 5
As last author 4
Unique topics 157
Collaborations 48
Sources 7
Are you Kathy Gately? Click here to provide feedback on your profile.
All
2020
2019
2018
2017
2016
2015
2014
2013
2011
All
2020
2019
2018
2017
2016
2015
2014
2013
2011

2020

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
2019

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells.
2018

Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines.
2017

Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines.
2017

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.
2016

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response
2016

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.
2016

Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer.
2015

In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC.
2015

Mutational analysis of the insulin-like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients.
2015

Targeting the fibroblast growth factor receptor family in cancer.
2015

Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
2015

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
2014

Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.
2014

The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training.
2014

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
2013

Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma.
2013

High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
2013

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.
2011

A role for IGF-1R-targeted therapies in small-cell lung cancer?
2011

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.
2011

Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification study.

These arethe7 unique sources for Kathy Gately's 22 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 3
Ireland -> Dublin City University -> PubMed 3
Ireland -> Maynooth University 1
Ireland -> Royal College of Surgeons in Ireland 2
Ireland -> Royal College of Surgeons in Ireland -> PubMed 1
Ireland -> Trinity College Dublin 17
Ireland -> Trinity College Dublin -> PubMed 11

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.